Finance

Lists
SGMT:NASDAQ
Sagimet Biosciences Inc
၈.၀၂ US$
-၁.၈၄%
(-၀.၁၅) 1D
၈.၀၂ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၁၆, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SGMT...
Open
၈.၁၅ US$
High
၈.၂၅ US$
Low
၇.၉၄ US$
Mkt. cap
၅၆.၅၇ ကုဋေ
Avg. vol.
၁.၄၀ သန်း
Volume
၁.၀၉ သန်း
52-wk high
၁၁.၄၅ US$
52-wk low
၄.၅၀ US$
EPS
-၁.၂၈ US$
Beta
၃.၄၆
Shares outstanding
၇.၀၃ ကုဋေ
No. of employees
၁၆
Open
၈.၁၅ US$
High
၈.၂၅ US$
Low
၇.၉၄ US$
Mkt. cap
၅၆.၅၇ ကုဋေ
Avg. vol.
၁.၄၀ သန်း
Volume
၁.၀၉ သန်း
52-wk high
၁၁.၄၅ US$
52-wk low
၄.၅၀ US$
EPS
-၁.၂၈ US$
Beta
၃.၄၆
Shares outstanding
၇.၀၃ ကုဋေ
No. of employees
၁၆
News stories
From web sources and news partners
About Sagimet Biosciences Inc
CEO-
Employees၁၆
Founded၂၀၀၆
HeadquartersSan Mateo, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitesagimet.com
Analyst ratings
Based on 12 analysts giving stock ratings to SGMT in the past 3 months
Strong buy
Buy
11
Hold
0
Sell
1
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for SGMT in the last 3 months.
Highest
Current ၈.၀၂ US$
၅၆.၀၀ US$ (+၅၉၈.၂၅%)
Average
၂၈.၄၆ US$ (+၂၅၄.၈၆%)
Lowest
၇.၀၀ US$ (-၁၂.၇၂%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
၂၉.၀၀ US$
+၂၆၁.၆%
10/05/2026
Seamus Fernandez
Guggenheim
Buy
Reiterated
၂၆.၀၀ US$
+၂၂၄.၂%
10/01/2026
Thomas Smith
Leerink Partners
Buy
Reiterated
-
-
10/01/2026
Andrea Newkirk
Goldman Sachs
Sell
Maintained
၇.၀၀ US$
-၁၂.၇%
09/30/2026
Jay Olson
Oppenheimer
Buy
Maintained
၃၈.၀၀ US$
+၃၇၃.၈%
10/01/2026
Edward Nash
Canaccord Genuity
Buy
Reiterated
၅၆.၀၀ US$
+၅၉၈.၃%
10/01/2026
Yanni Souroutzidis
Cantor Fitzgerald
Buy
Maintained
၂၅.၁၀ US$
+၂၁၃%
10/01/2026
Yun Zhong
Wedbush
Buy
Maintained
၂၈.၀၀ US$
+၂၄၉.၁%
10/01/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
၂၇.၀၀ US$
+၂၃၆.၇%
10/01/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
၂၈.၀၀ US$
+၂၄၉.၁%
09/30/2026
Debanjana Chatterjee
JonesTrading
Buy
Reiterated
၃၁.၀၀ US$
+၂၈၆.၅%
09/27/2026
Eliana Merle
Barclays
Buy
Upgraded
၁၈.၀၀ US$
+၁၂၄.၄%
09/09/2026
Ritu Baral
TD Cowen
Buy
Maintained
၂၁.၀၀ US$
+၁၆၁.၈%
05/12/2026
Unknown Analyst
Rodman & Renshaw
Buy
Initiated
၂၈.၀၀ US$
+၂၄၉.၁%
03/26/2026
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
၂၈.၀၀ US$
+၂၄၉.၁%
03/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၉.၇၃ သန်း
၆.၇၃ သန်း
၇.၀၀ သန်း
၁.၁၅ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄.၆၀ သန်း
၄.၀၃ သန်း
၄.၇၂ သန်း
၄.၂၈ သန်း
Operating expense
၁.၄၃ ကုဋေ
၁.၀၈ ကုဋေ
၁.၁၇ ကုဋေ
၁.၅၈ ကုဋေ
Total operating expenses
၁.၄၃ ကုဋေ
၁.၀၈ ကုဋေ
၁.၁၇ ကုဋေ
၁.၅၈ ကုဋေ
Operating income
-၁.၄၃ ကုဋေ
-၁.၀၈ ကုဋေ
-၁.၁၇ ကုဋေ
-၁.၅၈ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
-၁.၂၉ ကုဋေ
-၉.၅၇ သန်း
-၁.၀၆ ကုဋေ
-၁.၄၀ ကုဋေ
EBT excluding unusual items
-၁.၂၉ ကုဋေ
-၉.၅၇ သန်း
-၁.၀၆ ကုဋေ
-၁.၄၀ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၂၉ ကုဋေ
-၉.၅၇ သန်း
-၁.၀၆ ကုဋေ
-၁.၄၀ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၄၀
-၀.၂၉
-၀.၃၃
-၀.၂၆
Interest and investment income
၁.၄၃ သန်း
၁.၂၀ သန်း
၁.၀၆ သန်း
၁.၈၆ သန်း
Interest expense
-
-
-
-
Net interest expenses
၁.၄၃ သန်း
၁.၂၀ သန်း
၁.၀၆ သန်း
၁.၈၆ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google အက်ပ်များ